VolitionRx Limited (VNRX)
NYSEAMERICAN: VNRX · Real-Time Price · USD
0.3323
-0.0173 (-4.95%)
At close: Sep 8, 2026, 4:00 PM EDT
0.3317
-0.0179 (-5.12%)
Pre-market: Sep 9, 2026, 7:26 AM EDT
VolitionRx Employees
VolitionRx had 57 employees as of June 30, 2026. The number of employees decreased by 13 or -18.57% compared to the same quarter last year.
Employees
57
Change
-13
Growth
-18.57%
Revenue / Employee
$43,124
Profits / Employee
-$457,897
Market Cap
4.72M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 57 | -13 | -18.57% | 57 | 0 |
| Mar 31, 2026 | 67 | -15 | -18.29% | 67 | 0 |
| Dec 31, 2025 | 75 | -10 | -11.76% | 75 | 0 |
| Sep 30, 2025 | 75 | -21 | -21.88% | 75 | 0 |
| Jun 30, 2025 | 70 | -31 | -30.69% | 70 | 0 |
| Mar 31, 2025 | 82 | -26 | -24.07% | 82 | 0 |
| Dec 31, 2024 | 85 | -25 | -22.73% | 85 | 0 |
| Sep 30, 2024 | 96 | -18 | -15.79% | 96 | 0 |
| Jun 30, 2024 | 101 | -10 | -9.01% | 101 | 0 |
| Mar 31, 2024 | 108 | 4 | 3.85% | 108 | 0 |
| Dec 31, 2023 | 110 | 6 | 5.77% | 110 | 0 |
| Sep 30, 2023 | 114 | 15 | 15.15% | 114 | 0 |
| Jun 30, 2023 | 111 | 12 | 12.12% | 111 | 0 |
| Dec 31, 2022 | 104 | 21 | 25.30% | 104 | 0 |
| Jun 30, 2022 | 99 | - | - | 99 | 0 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Vivos Therapeutics | 270 |
| WORK Medical Technology Group LTD | 238 |
| Co-Diagnostics | 115 |
| IceCure Medical | 69 |
| Intelligent Bio Solutions | 60 |
| Beyond Air | 54 |
| ENvue Medical | 14 |
| Autonomix Medical | 11 |
VNRX News
- 1 day ago - VolitionRx Registration statement: Registration filing - Filings
- 11 days ago - VolitionRx files to sell 10.01M shares of common stock for holders - TheFly
- 12 days ago - VolitionRx Registration statement: Registration filing - Filings
- 13 days ago - VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets - PRNewsWire
- 13 days ago - VolitionRx announces publication on Nu.Q NETs H3.1 biomarker - TheFly
- 13 days ago - Volition Announces Landmark Clinical Validation of Nu.Q® NETs Biomarker in Sepsis - PRNewsWire
- 23 days ago - VolitionRx reports results from lateral flow finger prick sample test for sepsis - TheFly
- 23 days ago - VolitionRx reports Q2 revenue $400K, consensus $474.34K - TheFly